Advertisement
Research Article

A Malaria Vaccine That Elicits in Humans Antibodies Able to Kill Plasmodium falciparum

  • Pierre Druilhe mail,

    To whom correspondence should be addressed. E-mail: druilhe@pasteur.fr

    Affiliation: Biomedical Parasitology Unit, Pasteur Institute, Paris, France

    X
  • François Spertini,

    Affiliation: Division of Immunology and Allergy, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland

    X
  • Daw Soesoe,

    Affiliation: Biomedical Parasitology Unit, Pasteur Institute, Paris, France

    X
  • Giampietro Corradin,

    Affiliation: Institute of Biochemistry, University of Lausanne, Epalinges, Switzerland

    X
  • Pedro Mejia,

    Affiliation: Biomedical Parasitology Unit, Pasteur Institute, Paris, France

    X
  • Subhash Singh,

    Affiliation: Biomedical Parasitology Unit, Pasteur Institute, Paris, France

    X
  • Regine Audran,

    Affiliation: Division of Immunology and Allergy, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland

    X
  • Ahmed Bouzidi,

    Affiliation: Sedac Therapeutics, Lille, France

    X
  • Claude Oeuvray,

    Affiliation: Biomedical Parasitology Unit, Pasteur Institute, Paris, France

    X
  • Christian Roussilhon

    Affiliation: Biomedical Parasitology Unit, Pasteur Institute, Paris, France

    X
  • Published: November 08, 2005
  • DOI: 10.1371/journal.pmed.0020344

Media Coverage of this Article

Found additional news media or blog coverage for the article? Please let us know.

Linked Articles

Malaria Vaccine Yields Parasite-Killing Antibodies in Human Volunteers

Synopsis | published 8 Nov 2005 | PLOS Medicine
doi:10.1371/journal.pmed.0020408

Promising Functional Readouts of Immunity in a Blood-Stage Malaria Vaccine Trial

Brendan S Crabb, James G Beeson
Perspective | published 8 Nov 2005 | PLOS Medicine
doi:10.1371/journal.pmed.0020380